Schneider Jennifer

Schneider Jennifer is listed in filings as Director at Vertex Pharmaceuticals Inc. This profile follows SEC Form 4 activity through May 5, 2026, including 5 public disclosures. Recent filings connect the profile to Vertex Pharmaceuticals Inc (VRTX). The current snapshot covers public activity from May 5, 2025 to May 5, 2026. Reported amounts are shown as $608.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.